BioPharm International November 2016

November 2016 | Volume 29, Issue 11
Cover Story
Advances in technology are increasing the productivity and efficiency of commercial-scale chromatography bioprocesses.
Features
This article demonstrates that a modified SDS–PAGE can be easily used as a tool for quantifying the degree of protein degradation.
New data analytics tools help solve complex problems in a biotherapeutic development process.
In addition to having the optimal cell line and process, it is crucial to have the optimal cell culture medium and feed to maximize performance potential.
The development of mAb formulations poses challenges at the manufacturing, stability, analytical, and administration levels.
Interactions between biologic drug products and the components of prefilled syringes can cause protein aggregation, but there are alternative materials that can help mitigate this problem.
Peer-Reviewed Research
To investigate the best culture conditions, the authors used response surface methodology via Box-Behnken design.
Supply Chain
Vendor selection and materials testing are complex enough, but in today’s volatile environment, risk mapping and monitoring are also crucial.
Regulatory Beat
Reliable, high-quality products require innovative analytics and production.
Perspectives on Outsourcing
CMO executives are focusing on M&A activity, new business models, and fundraising limits.
Ask the Expert
Siegfried Schmitt, PhD, principal consultant, PAREXEL, discusses how to prepare for an inspection by a foreign regulatory agency.
From the Editor
CPhI Pharma Award winners were recognized for sweating the details for the bigger picture.
native1_300x100
lorem ipsum